Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-08-2017 | Original Article

Reduction in fecal microbiota diversity and short-chain fatty acid producers in Methicillin-resistant Staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology

Authors: J. Zhao, L. Nian, L. Y. Kwok, T. Sun, J. Zhao

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2017

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) may cause potentially lethal infections. Increasing evidence suggests that the gut microbiota is associated with human health. Yet, whether patients with MRSA infections carry specific signatures in their fecal microbiota composition has not been determined. Thus, this study aimed to compare the fecal microbiota profile of MRSA-positive patients (n=15) with individuals without MRSA infection (n=15) by using the PacBio single molecule, real-time (SMRT) DNA sequencing system and real-time quantitative polymerase chain reaction (qPCR). Mann-Whitney tests and unweighted UniFrac principal coordinate analysis (PCoA) showed that the profile of fecal microbiota was apparently different between the two populations. Both the community richness and diversity were reduced in the MRSA-positive group (p<0.050). The genera Acinetobacter and Enterococcus were highly enriched in the MRSA-positive group, whereas less short-chain fatty acid (SCFA)-producing bacteria, including Butyricimonas, Faecalibacterium, Roseburia, Ruminococcus, Megamonas and Phascolarctobacterium, were detected in the MRSA-positive group. At species level, the species Acinetobacter baumannii and Bacteroides thetaiotaomicron were prevalent in the MRSA-positive group, whereas opposite trends were observed in 17 other species, such as Faecalibacterium prausnitzii, Lactobacillus rogosae, Megamonas rupellensis and Phascolarctobacterium faecium. Positive correlations were observed between Acinetobacter baumannii and erythrocyte sedimentation rate (ESR) (R=0.554, p=0.001), as well as hypersensitive C reactive protein (hsCRP) (R=0.406, p=0.026). Faecalibacterium prausnitzii was negatively associated with ESR (R=-0.545, p=0.002), hsCRP (R=-0.401, p=0.028) and total bile acids (TBA) (R=-0.364, p=0.048). In conclusion, the fecal microbiota structure was different between MRSA-positive and -negative patients. The increase in potential pathogens with the reduction of beneficial populations, such as SCFA-producing bacteria, in MRSA-positive patients may affect prognosis.

Available only for authorised users

Qin N, Tan X, Jiao Y, Liu L, Zhao W, Yang S, Jia A (2013) RNA-Seq-based transcriptome analysis of methicillin-resistant Staphylococcus aureus biofilm inhibition by ursolic acid and resveratrol. Sci Rep 4:5467–5467. doi:10.1038/srep05467

Haaber J, Cohn MT, Frees D, Andersen TJ, Ingmer H (2012) Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. J Infect Dis 205(11):1688–1696. doi:10.1371/journal.pone.0041075

Thangamani S, Younis W, Seleem MN (2015) Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. Sci Rep 5. doi:10.1038/srep11596

Adamu BO, Lawley TD (2013) Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 16(5):596–601. doi:10.1016/j.mib.2013.06.009

Hartstra AV, Nieuwdorp M, Herrema H (2016) Interplay between gut microbiota, its metabolites and human metabolism: dissecting cause from consequence. Trends Food Sci Technol. doi:10.1016/j.tifs.2016.08.009

Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM, Huang Y, Somsouk M (2013) Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 5(193):3390–3396. doi:10.1126/scitranslmed.3006438 CrossRef

Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Wei J, Cai S, Zhao L (2012) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6(2):320–329. doi:10.1038/ismej.2011.109 PubMedCrossRef

Wei Y, Gong J, Zhu W, Guo D, Gu L, Li N, Li J (2015) Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis. BMC Infect Dis 15(1):1–8. doi:10.1186/s12879-015-0973-1

Brahe LK, Chatelier EL, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH (2015) Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutrit Diabetes 5(6):1755–1758. doi:10.1038/nutd.2015.9

10.

Carles U, Vanni B, Silvia C, Ana D, Toussaint NC, Michele E, Lauren L, Lilan L, Asia G, Daniel N (2013) Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 81(3):965–973. doi:10.1128/IAI.01197-12

11.

Magrini L, Gagliano G, Travaglino F, Vetrone F, Marino R, Cardelli P, Salerno G, Di SS (2014) Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med 52(10):1465–1472. doi:10.1515/cclm-2014-0210 PubMedCrossRef

12.

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336. doi:10.1038/nmeth.f.303 PubMedPubMedCentralCrossRef

13.

Caporaso JG, Bittinger K, Bushman FD, Desantis TZ, Andersen GL, Knight R (2010) PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26(2):266–267(262). doi:10.1093/bioinformatics/btp636 PubMedCrossRef

14.

Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460–2461. doi:10.1093/bioinformatics/btq461 PubMedCrossRef

15.

Cole JR, Chai B, Farris RJ, Wang Q, Kulam-Syed-Mohideen A, McGarrell DM, Bandela A, Cardenas E, Garrity GM, Tiedje JM (2007) The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res 35(suppl 1):D169–D172. doi:10.1093/nar/gkl889 PubMedCrossRef

16.

Price MN, Dehal PS, Arkin AP (2009) FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 26(7):1641–1650. doi:10.1093/molbev/msp077 PubMedPubMedCentralCrossRef

17.

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484. doi:10.1038/nature07540 PubMedCrossRef

18.

Mckenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Lozupone CA, Hamady M, Knight R, Bushman FD (2008) The Macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. Plos Pathogens 4(2):20. doi:10.1371/journal.ppat.0040020 CrossRef

19.

Mcmurtry VE, Gupta RW, Tran L, Blanchard EE, Penn D, Taylor CM, Ferris MJ (2014) Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome 3(1):1–8. doi:10.1186/s40168-015-0075-8

20.

Sakamoto M, Takagaki A, Matsumoto K, Kato Y, Goto K, Benno Y (2009) Butyricimonas synergistica gen. nov., sp. nov. and Butyricimonas virosa sp. nov., butyric acid-producing bacteria in the family ‘Porphyromonadaceae’ isolated from rat faeces. Int J Syst Evol Microbiol 59(Pt 7):1748–1753. doi:10.1099/ijs.0.007674-0

21.

Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Andoh A, Sugimoto M (2016) Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion 93(1):59–65. doi:10.1159/000441768 PubMedCrossRef

22.

Scupham AJ, Patton TG, Bent E, Bayles DO (2008) Comparison of the cecal microbiota of domestic and wild turkeys. Microb Ecol 56(2):322–331. doi:10.1007/s00248-007-9349-4 PubMedCrossRef

23.

Yohei W, Fumiko N, Masami M (2012) Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces. Appl Environ Microbiol 78(2):511–518. doi:10.1128/AEM.06035-11

24.

Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L (2014) Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific Reports 5. doi: 10.1038/srep14405

25.

Sartor RB (2010) Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology 139(6):1816–1819. doi:10.1053/j.gastro.2010.10.036 PubMedCrossRef

26.

Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562–572. doi:10.1002/hep.24423 PubMedCrossRef

27.

Zhang J, Guo Z, Xue Z, Sun Z, Zhang M, Wang L, Wang G, Wang F, Xu J, Cao H (2015) A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. Isme J Multidiscipl J Microb Ecol 9 (9). doi: 10.1038/ismej.2015.11

28.

Wang F, Yu T, Huang G, Cai D, Liang X, Su H, Zhu Z, Li D, Yang Y, Shen P (2015) Gut microbiota community and its assembly associated with age and diet in Chinese centenarians. J Microbiol Biotechnol 25(8):1195–1204. doi:10.4014/jmb.1410.10014 PubMedCrossRef

29.

Jangi S, Gandhi R, Cox LM, Li N, Glehn FV, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015. doi:10.1038/ncomms12015

30.

Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B (2014) Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52(2):398–406. doi:10.1128/JCM.01500-13

31.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2(1629):e01202. doi:10.7554/eLife.01202 PubMedPubMedCentral

32.

Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):2729–2732. doi:10.1038/nature13041 CrossRef

33.

Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA, Belkaid Y (2008) Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29(4):637–649. doi:10.1016/j.immuni.2008.08.009 PubMedPubMedCentralCrossRef

34.

Steinway SN, Biggs MB, Jr LT, Papin JA, Albert R (2015) Inference of network dynamics and metabolic interactions in the gut microbiome. Plos Comput Biol 11 (6). doi:10.1371/journal.pcbi.1004338

35.

Strati F, Cavalieri D, Albanese D, Felice CD, Donati C, Hayek J, Jousson O, Leoncini S, Pindo M, Renzi D (2016) Altered gut microbiota in Rett syndrome. Microbiome 4 (1). doi:10.1186/s40168-016-0185-y

36.

Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904. doi:10.1152/physrev.00045.2009 PubMedCrossRef

37.

Vonschillde MA, Hörmannsperger G, Weiher M, Alpert CA, Hahne H, Bäuerl C, Vanhuynegem K, Steidler L, Hrncir T, Pérez-Martínez G (2012) Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11(4):387–396. doi:10.1016/j.chom.2012.02.006

38.

Lăzureanu V, Poroșnicu M, Gândac C, Moisil T, Bădițoiu L, Laza R, Musta V, Crișan A, Marinescu AR (2016) Infection with Acinetobacter baumannii in an intensive care unit in the Western part of Romania. BMC Infect Dis 16(S1):23–28. doi:10.1186/s12879-016-1399-0

39.

Georgescu M, Gheorghe I, Dudu A, Czobor I, Costache M, Cristea VC et al (2016) First report of OXA-72 producing Acinetobacter baumanniiin in Romania. New Microbes New Infect 13:87–88. doi:10.1016/j.nmni.2016.07.004

40.

Haisma EM, Rietveld MH, De BA, van Dissel JT, El GA, Nibbering PH (2013) Inflammatory and antimicrobial responses to methicillin-resistant Staphylococcus aureus in an in vitro wound infection model. Plos One 8(12):1611–1614. doi:10.1371/journal.pone.0082800

41.

Muñoz-Planillo R, Franchi L, Miller LS, Núñez G (2009) A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 183(6):3942–3948. doi:10.4049/jimmunol.0900729

42.

Mcarthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, Bhullar K, Canova MJ, De PG, Ejim L (2013) The comprehensive antibiotic resistance database. Antimicrob Agents Chemotherapy 57(7):3348–3357. doi:10.1128/AAC.00419-13 CrossRef

43.

Sommer MO, Dantas G, Church GM (2009) Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325(5944):1128–1131. doi:10.4161/viru.1.4.12010 PubMedPubMedCentralCrossRef

44.

Gosalbes MJ, Vallès Y, Jiménez-Hernández N, Balle C, Riva P, Miravet-Verde S, de Vries LE, Llop S, Agersø Y, Sørensen SJ (2015) High frequencies of antibiotic resistance genes in infants’ meconium and early fecal samples. J Dev Origins Health Dis 1(1):1–10. doi:10.1017/S2040174415001506

45.

Ubukata K, Nonoguchi R, Matsuhashi M, Konno M (1989) Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol 171(5):2882–2885. doi:10.1128/jb.171.5.2882-2885.1989

46.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdezhumarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105(43):16731–16736. doi:10.1073/pnas.0804812105

47.

Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdezhumarán LG, Pigneur B (2015) Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 194(5003):127–128. doi:10.1136/gutjnl-2014-307649

Title: Reduction in fecal microbiota diversity and short-chain fatty acid producers in Methicillin-resistant Staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology
Authors: J. Zhao
L. Nian
L. Y. Kwok
T. Sun
J. Zhao
Publication date: 01-08-2017
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-2955-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2017

Clinical case of cfr-positive MRSA CC398 in Belgium

Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps

Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome

Current trends of human infections and antibiotic resistance of the genus Shewanella

Silver-embedded screens in the intensive care unit. A new tool to control multi-drug resistant bacterial cross-transmission

Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials